GLP-1 Receptor Agonists Explained: Weight Loss Injections

Understanding GLP-1 Receptor Agonists

GLP-1 receptor agonists are a class of medications initially developed for the treatment of type 2 diabetes. However, their significant impact on weight loss has led to their increased use for weight management in individuals with obesity or who are overweight with related health conditions. These medications mimic the effects of glucagon-like peptide-1 (GLP-1), a natural hormone in the body that plays a crucial role in regulating appetite and blood sugar levels.

Key Point 1 GLP-1 receptor agonists mimic a natural hormone to regulate appetite and blood sugar.

Key Point 2 These medications promote significant weight loss by reducing appetite and increasing feelings of fullness.

Key Point 3 Treatments like Wegovy (semaglutide) and Mounjaro (tirzepatide) are highly effective GLP-1 receptor agonists.

Key Point 4 Hi Doctor AI offers convenient online consultations with EU-licensed doctors to determine if GLP-1 medications are right for you.

How GLP-1 Agonists Work for Weight Loss

GLP-1 receptor agonists work through several mechanisms to promote weight loss:

• Appetite Reduction: They reduce appetite by signaling to the brain that you are full, leading to decreased food intake.
• Slower Gastric Emptying: These medications slow down the rate at which food leaves the stomach, prolonging the feeling of fullness and reducing the urge to eat more frequently.
• Blood Sugar Regulation: By improving insulin secretion and reducing glucagon production, GLP-1 receptor agonists help regulate blood sugar levels, which can contribute to weight loss and overall metabolic health.

Commonly prescribed GLP-1 receptor agonists include semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda), and tirzepatide (Mounjaro). These medications are administered via subcutaneous injection.

Hi Doctor AI provides telemedicine consultations. All treatments are prescribed by EU-licensed doctors after reviewing your medical history. We do not sell or ship medications—prescriptions can be used at any licensed pharmacy in the EU.

Expected Results and Treatment Timeline

The amount of weight loss achieved with GLP-1 receptor agonists can vary depending on the individual, the specific medication used, and lifestyle factors such as diet and exercise. Clinical trials have shown that individuals using semaglutide (Wegovy) can achieve an average weight loss of 15-17% of their body weight over 68 weeks. Tirzepatide (Mounjaro) has demonstrated even more impressive results, with average weight loss reaching 22.5% after 72 weeks. Liraglutide (Saxenda) typically results in about 8% weight loss after 56 weeks.

A typical treatment timeline looks like this:

• Week 1-4 (Month 1): Initial adjustment period as the body adapts to the medication. Appetite reduction and decreased food cravings begin, and initial weight loss starts.
• Month 2-3: Consistent weight reduction, visible changes in body composition, improved energy levels, and better control of eating habits.
• Month 4-6: Clinically significant weight loss (10-15% or more), reaching target weight, and establishing maintenance habits.
• Month 6+: Long-term maintenance phase, focusing on maintaining a healthy weight with continued medical support.

Potential Side Effects and Considerations

Like all medications, GLP-1 receptor agonists can cause side effects. Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain. These side effects are usually mild to moderate and tend to improve over time as the body adjusts to the medication. However, some individuals may experience more severe side effects, such as pancreatitis or gallbladder problems.

It is essential to discuss your medical history and any existing health conditions with your doctor before starting GLP-1 receptor agonists. These medications may not be suitable for individuals with certain medical conditions, such as a history of pancreatitis or certain types of thyroid cancer.

How Hi Doctor AI Helps

Hi Doctor AI offers a convenient and discreet way to access medical consultations for weight management. Our EU-licensed doctors can assess your medical history, discuss your weight loss goals, and determine if GLP-1 receptor agonists are a suitable treatment option for you. The process is 100% online, eliminating the need for in-person visits. With Hi Doctor AI, you can receive a valid EU prescription in under 24 hours, which can be used at any licensed pharmacy within the EU. If a prescription is not issued, you will receive a full refund of the consultation fee.

Ready to Get Started?

Ready to start your weight loss journey? Get your online consultation with Hi Doctor AI—EU-licensed doctors, 45€ consultation fee.